长春高新 (000661)

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

ASZ

Tags

300ESG Index300 Non-Cyclical IndexAI AgentsMSCI Component StocksSpecial Purpose LoansMid Cap ValueCSI 200 IndexCSI A100 IndexCSI Leading Enterprises IndexGeneric DrugsInnovative DrugsMedical Aesthetics ConceptState-Owned Enterprise ReformGuozheng Value IndexGuozheng Growth IndexGuozheng Corporate Governance IndexGene ConceptFund Heavy PositionsLarge Cap GrowthEmerging Markets IndexBiological ProductsBiological VaccinesSocial Security HeavyHigh-Performing StocksChina Securities Finance and Central Huijin HoldingsAssisted ReproductionNon-Cyclical StocksShenzhen Main Board 50 IndexShenzhen ConnectSZSE 100 IndexSZSE 300 IndexSZSE Value IndexSZSE Growth IndexSZSE Governance IndexTech 100 IndexPharma & BiotechTechnology Leaders IndexSHS Technology Leaders IndexConsumer Services IndexSZSE Medicine Equal Weight IndexSZSE 100 Equal Weight IndexEqual Weight 90 IndexCSI Emerging Industries IndexJuchao Large-cap IndexShenzhen A-Share Pharmaceutical IndexBOC International CSI 300 ESG IndexCSI 300 Quality IndexCSI 100 Low Volatility IndexCS High Dividend Yield IndexCSI All-share Pharmaceutical Sector IndexEmerging Technology 100 IndexSZSE Emerging Industries IndexSHS Technology 100 IndexSZSE 1000 IndexSZSE 300 Return IndexCSSW Health IndexCSI 1000 Growth IndexSZSE Component Index ReturnCSI 300 Equal Weight IndexCSI 300 ESG IndexLarge & Mid-cap IndexCSWD Life Sciences IndexShanghai-Hong Kong-Shenzhen 300 IndexCNI 1000 IndexXingyin Wealth Management Balanced 300 IndexBiomedicine IndexCSSW Silk Road IndexGrowth 40 IndexState-owned Enterprises Belt and Road IndexRestructuringSpin-off Listing ExpectationConvertible Bond IssuersInternal Employee SharesLocal State-owned Assets ReformPrivate PlacementFTSE Russell ConceptHuijin ConceptShareholding Increase CommitmentLarge-cap Blue-chipNEEQPrecision MedicineAntiviralCSI 300 Non-cyclical IndexCNI Emerging Industries IndexTechnology 50 IndexPension Industry IndexSZSE Selected IndexSZSE Responsibility IndexTechnology 50 Strategy IndexCS High-end Manufacturing IndexAdvanced Manufacturing IndexVaccine & Biotech IndexCSI 300 Shenzhen Market IndexSZSE Technology IndexSZSE Leaders IndexEmerging Industries Composite IndexSZSE 100 Return IndexManufacturing IndexSHS Innovative Drugs IndexSZSE High Beta IndexTechnology Pioneer IndexSZSE ChiNext 100 IndexSustainable Development IndexCSI 300 Growth IndexSecurities Times Value 100 IndexSZSE Pharmaceutical IndexCSI 800 IndexCS Pharmaceutical TI Index100 Performance IndexCSI 300 Preferred IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexCNI 300 IndexCCTV 500 IndexCSI 300 USD (CNH) IndexHua Xia Bank ESG IndexCS Pharmaceutical Innovation IndexSZSE Component Pharmaceutical IndexPharmaceutical Sub-sector IndexCSI All-share Pharmaceutical IndexCSI 300 USD IndexSZSE Pharmaceutical 50 IndexSmart Select 300 ESG Leading IndexSZSE 300 Equal Weight IndexCSI Pharmaceutical IndexCSI 800 Pharmaceutical IndexSZSE Component Index Equal WeightCS Biomedicine IndexPharmaceutical & Health 100 IndexInnovative Drugs 30 IndexCSI 300 Pharmaceutical IndexCSI 700 IndexAH Economic Blue-chip IndexMid-small Cap IndexSZSE Fundamental 200 IndexPharmaceutical 50 IndexPharmaceutical 50 Strategy IndexCSI Life Sciences IndexCS Innovative Drugs IndexESG 300 IndexCR New Momentum IndexOrient Securities Competition IndexChina Economic Index GDPJuchao Mid-cap IndexCSI 1000 Value IndexSZSE Fundamental 120 IndexFundamental 600 IndexCSI 300 Growth Innovation IndexCSI 800 Cash Flow IndexStrategic Emerging Industries 100 IndexJilin

K-Line Chart

No K-line data available

Company NameChangchun High-Tech Industry (Group) Co., Ltd.
Listing Date1996-12-18
Issue Price8.8RMB
Registered Capital40793.752910k RMB
Legal RepresentativeJiang Yuntao
Registered AddressRoom 2708, Block B, Hairong Hotel & Haiyin Plaza Office Building, Changchun City, Jilin Province
IndustryBiological Products
Main BusinessNew drug development, technology transfer, technical consulting services, development, production, sales and service of high-tech products, infrastructure development, construction, property management, central heating, transfer and intermediary services of high-tech achievements, commercial supply and marketing (excluding commodities subject to special state restrictions), industrial investment (pharmaceutical industry, high-tech industry), catering and entertainment, hotels, training
Company ProfileChangchun High-Tech Industry (Group) Co., Ltd. was established in June 1993. The company's stock was listed on the Main Board (A-shares) of the Shenzhen Stock Exchange on December 18, 1996, becoming one of the earliest listed companies in Northeast China. The company's unified social credit code is 91220101243899305A. As of now, the company's total share capital is 170,112,265 shares. The company's main business focuses on biopharmaceuticals, production and sales of Chinese patent medicines, supplemented by real estate development, property management, etc. Over the 20 years since listing, the company has refined and adhered to the development philosophy of 'Innovation, Focus, Inclusiveness, and Sharing'. It insists on technological innovation as the driving force. The leading industry has successfully transformed from serving infrastructure construction in the development zone to biopharmaceuticals and the health industry. With the successful incubation and growth of pharmaceutical industry projects, it has supported the rapid growth of operating performance. Currently, the company has become a listed company with certain technological leading advantages in the domestic biopharmaceutical field.

Stock Details

1. Key Indicators

  • Total Shares(W): 40793.75
  • Circulating A-Shares(W): 39961.46
  • Earnings Per Share(RMB): 2.9000
  • Net Assets Per Share(RMB): 56.3989
  • Operating Revenue(W RMB): 980661.29
  • Total Profit(W RMB): 118045.43
  • Net Profit Attributable to Parent(W RMB): 116487.99
  • Net Profit Growth Rate(%): -58.23
  • Weighted Return on Equity(%): 5.0300
  • Operating Cash Flow Per Share(RMB): 1.7700
  • Undistributed Profit Per Share(RMB): 43.1530
  • Capital Reserve Per Share(RMB): 8.5301

2. Main Business

The main business covers:

  • Research, development, production and sales of biopharmaceuticals and Chinese patent medicines
  • Real estate development and other businesses

3. Company Basic Information

  • Company Name: Changchun High-Tech Industry (Group) Co., Ltd.
  • Listing Date: 1996-12-18
  • Industry: Pharmaceutical Manufacturing
  • Address: 27th Floor, Block B, Hairong Plaza, High-tech Zone, Changchun City, Jilin Province (Intersection of Zhenyu Street and East Weishan Road)
  • Website: ccht.jl.cn
  • Company Profile: The company was exclusively initiated and established by Changchun High-tech Industry General Company in June 1993. Initially, its net assets were converted into 104.7 million state shares, 6 million corporate shares, and 26.8 million employee shares. After a 2.5:1 share consolidation in October 1996 and the first online pricing issuance on December 3, 1996, the total shares at listing were 68.64 million. The 5.36 million internal employee shares, which occupied the quota, were listed for trading together with its 13.64 million public shares on December 18, 1996.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Changchun Chaoda Investment Group Co., Ltd. General Legal Person 7625.65 19.08
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 974.51 2.44
3 Central Huijin Asset Management Co., Ltd. Special Legal Person 642.72 1.61
4 Huatai-PineBridge CSI 300 ETF Fund 551.83 1.38
5 China Merchants SSE Bio-medicine Index LOF (Class A) Fund 430.37 1.08
6 Xingquan Herun Hybrid LOF (Class A) Fund 412.79 1.03
7 E Fund CSI 300 Healthcare ETF Fund 409.12 1.02
8 E Fund CSI 300 ETF Fund 400.86 1.00
9 Yinhua CSI Innovative Pharma Industry ETF Fund 315.45 0.79
10 E Fund Healthcare Industry Hybrid (Class A) Fund 166.61 0.42

5. Concept Sectors

  • Biological Vaccine
  • Gene Concept
  • Generic Drug
  • Medical Aesthetics Concept
  • Assisted Reproduction
  • Innovative Drug
  • AI Agent
  • AI Healthcare
  • Margin Trading
  • Blue Chip Stock
  • Fund Heavy Holdings
  • Central Huijin & China Securities Finance
  • MSCI Constituent
  • Spin-off Listing
  • Non-cyclical Stock
  • Special Loan
  • SZSE Value
  • Mid-cap Value
  • SZSE 100
  • SZSE 300
  • SZSE Governance
  • SZSE Composite Governance
  • SZSE Composite Value
  • CSI 300
  • CSI 200
  • CSI 300 Non-Cyclical
  • Innovation 100
  • CSI 300 ESG
  • SOE Reform
  • SZSE 50
  • SZSE Main Board 50

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information